(Q38920677)

16 June 2018

title

Trial design for evaluating novel treatments during an outbreak of an infectious disease (English)

1 reference

16 June 2018

author

Peter W. Horby

series ordinal

4

1 reference

16 June 2018

Piero Olliaro

series ordinal

2

object named as

Piero Olliaro

1 reference

16 June 2018

Trudie Lang

series ordinal

3

object named as

Trudie Lang

1 reference

16 June 2018

John Whitehead

1

1 reference

16 June 2018

publication date

14 January 2016

1 reference

16 June 2018

published in

Clinical Trials

1 reference

16 June 2018

volume

13

1 reference

16 June 2018

issue

1

1 reference

16 June 2018

page(s)

31-38

1 reference

16 June 2018

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5856305

Evaluating clinical trial designs for investigational treatments of Ebola virus disease

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5856305

Bayesian methods for setting sample sizes and choosing allocation ratios in phase II clinical trials with time-to-event endpoints

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5856305

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5856305

Bayesian sample size for exploratory clinical trials incorporating historical data

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5856305

Overrunning and underrunning in sequential clinical trials

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5856305

Bayesian methods for the design and interpretation of clinical trials in very rare diseases

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5856305

An exact method for analysis following a two-stage phase II cancer clinical trial

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5856305

Designing phase II studies in the context of a programme of clinical research

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5856305

Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment

22 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26768556

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/1740774515617740

1 reference

16 June 2018

PMCID

5856305

1 reference

16 June 2018

PubMed ID

26768556

1 reference

16 June 2018